Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Alivexis is a technology-driven drug discovery company developing small-molecule therapeutics for oncology, chronic inflammation and immune disorders, and rare genetic diseases. The company integrates unique core biology insights with a supercomputer-powered discovery platform and scalable networked operations to advance its proprietary programs and collaborative projects. It operates offices in Tokyo and Boston and focuses on efficient delivery of breakthrough medicines for patients with unmet medical needs.